Overview

Evaluation of Efficacy and Safety of SDN-037

Status:
Completed

Trial end date:
2020-03-05

Target enrollment:

Participant gender:

Summary

The efficacy and safety of SDN-037 twice daily will be evaluated and compared with vehicle for the treatment of inflammation and pain associated with ocular surgery.

Phase:

Phase 3

Details

Lead Sponsor:

Sun Pharma Advanced Research Company Limited